Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Glehnia root has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
The root polysaccharide binds iron into a complex that stays intact through simulated gastric conditions and releases it further down. Complexing iron this way is a known route to reducing the free-iron irritation that plain salts cause. The work was a laboratory digestion and fermentation model, so uptake in a person has not been measured.
Glehnia polysaccharide reached the fermentation stage largely undigested and shifted the bacterial community composition in vitro. That is the defining behaviour of a prebiotic substrate. The measured endpoint was community composition, which is a marker rather than a health outcome.
Fermentable polysaccharides of different structures feed partly different organisms and produce different short-chain fatty acid ratios. Combining them broadens the substrate range rather than doubling one. Direct comparison of glehnia polysaccharide against inulin in people has not been done.
Apiaceae roots of this type carry furanocoumarins such as imperatorin and psoralen, and that compound class inhibits CYP3A4 and CYP2C9 in the gut wall and liver. Berberine inhibits the same enzyme. Stacked, they slow clearance of anything else that depends on that route, which matters most for people on prescription medicines.
St John's Wort induces CYP3A4 while furanocoumarins inhibit it, so the two push clearance in opposite directions and the net result is unpredictable rather than neutral. That unpredictability is the reason to separate them rather than assume they cancel out. This is enzyme-level pharmacology, not a clinical study of the pair.
Psoralen-type coumarins raise skin sensitivity to ultraviolet light, so deliberate sun exposure becomes a poorer idea while taking a coumarin-rich extract. Anyone relying on sunlight rather than a supplement for vitamin D status should know that. The photosensitising chemistry is well described for the compound class; the size of the effect for a normal culinary dose of this root is not.
Nothing specific on file for Glehnia root. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 1 we read for Glehnia root. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.